Principal Financial Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,731
| Closed | -$10K | – | 2273 |
|
|
2016
Q1 | $10K | Sell |
1,731
-89,450
| -98% | -$517K | ﹤0.01% | 2168 |
|
|
2015
Q4 | $1.57M | Hold |
91,181
| – | – | ﹤0.01% | 1692 |
|
|
2015
Q3 | $1.92M | Buy |
91,181
+37,959
| +71% | +$801K | ﹤0.01% | 1655 |
|
|
2015
Q2 | $2.63M | Buy |
53,222
+5,155
| +11% | +$255K | ﹤0.01% | 1624 |
|
|
2015
Q1 | $3.76M | Sell |
48,067
-271
| -0.6% | -$21.2K | 0.01% | 1488 |
|
|
2014
Q4 | $2.93M | Sell |
48,338
-3,529
| -7% | -$214K | ﹤0.01% | 1595 |
|
|
2014
Q3 | $2.21M | Buy |
51,867
+1,784
| +4% | +$76K | ﹤0.01% | 1634 |
|
|
2014
Q2 | $3.1M | Sell |
50,083
-667
| -1% | -$41.2K | 0.01% | 1596 |
|
|
2014
Q1 | $3.3M | Buy |
50,750
+1,960
| +4% | +$127K | 0.01% | 1547 |
|
|
2013
Q4 | $2.75M | Buy |
48,790
+790
| +2% | +$44.5K | 0.01% | 1608 |
|
|
2013
Q3 | $2.95M | Sell |
48,000
-3,145
| -6% | -$193K | 0.01% | 1531 |
|
|
2013
Q2 | $2.99M | Buy |
+51,145
| New | +$2.99M | 0.01% | 1469 |
|